{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:55:54Z","timestamp":1780372554994,"version":"3.54.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Myoung-Sun Kim Memorial Foundation","award":["2017"],"award-info":[{"award-number":["2017"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230227","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T17:40:31Z","timestamp":1584466831000},"page":"e0230227","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["AdipoRon, adiponectin receptor agonist, improves vascular function in the mesenteric arteries of type 2 diabetic mice"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7115-6358","authenticated-orcid":true,"given":"Soo-Kyoung","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngin","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonhee","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Eun","family":"Haam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"pone.0230227.ref001","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archinte.161.13.1581","article-title":"Impact of overweight on the risk of developing common chronic diseases during a 10-year period","volume":"161","author":"AE Field","year":"2001","journal-title":"Arch Intern Med"},{"key":"pone.0230227.ref002","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"M Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"pone.0230227.ref003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00024677-200504020-00001","article-title":"Diabesity: are weight loss medications effective?","volume":"4","author":"A Halpern","year":"2005","journal-title":"Treat Endocrinol"},{"key":"pone.0230227.ref004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14779072.7.3.209","article-title":"Vascular dysfunction in Type 2 diabetes: emerging targets for therapy","volume":"7","author":"Y Park","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"pone.0230227.ref005","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"K Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0230227.ref006","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"C Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0230227.ref007","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.50.9.2094","article-title":"PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein","volume":"50","author":"N Maeda","year":"2001","journal-title":"Diabetes"},{"key":"pone.0230227.ref008","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"AH Berg","year":"2001","journal-title":"Nat Med"},{"key":"pone.0230227.ref009","doi-asserted-by":"crossref","first-page":"31608","DOI":"10.1074\/jbc.M109.010355","article-title":"Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells","volume":"284","author":"C Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"pone.0230227.ref010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1475-2840-12-46","article-title":"Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats","volume":"12","author":"PM Schmid","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"pone.0230227.ref011","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2017.01.018","article-title":"APPLs: More than just adiponectin receptor binding proteins","volume":"32","author":"Z Liu","year":"2017","journal-title":"Cell Signal"},{"key":"pone.0230227.ref012","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"M Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"pone.0230227.ref013","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1126\/science.1249077","article-title":"Cell Biology. Ronning after the adiponectin receptors","volume":"342","author":"WL Holland","year":"2013","journal-title":"Science"},{"key":"pone.0230227.ref014","doi-asserted-by":"crossref","first-page":"e84194","DOI":"10.1371\/journal.pone.0084194","article-title":"Role of endogenous ENaC and TRP channels in the myogenic response of rat posterior cerebral arteries","volume":"8","author":"EC Kim","year":"2013","journal-title":"PLoS One"},{"key":"pone.0230227.ref015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cvr\/cvp054","article-title":"Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery","volume":"82","author":"SK Choi","year":"2009","journal-title":"Cardiovasc Res"},{"key":"pone.0230227.ref016","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00424-006-0133-y","article-title":"Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction","volume":"453","author":"MH Tsai","year":"2006","journal-title":"Pflugers Arch"},{"key":"pone.0230227.ref017","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/cphy.c170046","article-title":"Adiponectin Regulation and Function","volume":"8","author":"H Fang","year":"2018","journal-title":"Compr Physiol"},{"key":"pone.0230227.ref018","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"M Chandran","year":"2003","journal-title":"Diabetes Care"},{"key":"pone.0230227.ref019","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1113\/jphysiol.1902.sp000911","article-title":"On the local reactions of the arterial wall to changes of internal pressure","volume":"28","author":"WM Bayliss","year":"1902","journal-title":"J Physiol"},{"key":"pone.0230227.ref020","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1159\/000051094","article-title":"Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries","volume":"38","author":"GJ Lagaud","year":"2001","journal-title":"J Vasc Res"},{"key":"pone.0230227.ref021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/micc.12266","article-title":"Adiponectin Receptor Agonist, AdipoRon, Causes Vasorelaxation Predominantly Via a Direct Smooth Muscle Action","volume":"23","author":"K Hong","year":"2016","journal-title":"Microcirculation"},{"key":"pone.0230227.ref022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beem.2013.09.003","article-title":"Adiponectin receptors: a review of their structure, function and how they work","volume":"28","author":"T Yamauchi","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"pone.0230227.ref023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(13)70120-7","article-title":"Adiponectin and its receptors: implications for obesity-associated diseases and longevity","volume":"2","author":"T Kadowaki","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0230227.ref024","first-page":"1769","article-title":"Expression of adiponectin and its receptors in type 1 diabetes mellitus in human and mouse retinas","volume":"19","author":"T Lin","year":"2013","journal-title":"Mol Vis"},{"key":"pone.0230227.ref025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00125-004-1394-7","article-title":"Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients","volume":"47","author":"C Debard","year":"2004","journal-title":"Diabetologia"},{"key":"pone.0230227.ref026","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1007\/s00125-011-2173-x","article-title":"Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling","volume":"54","author":"RM Holmes","year":"2011","journal-title":"Diabetologia"},{"key":"pone.0230227.ref027","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ijo.2009.205","article-title":"Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway","volume":"34","author":"G Deng","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"pone.0230227.ref028","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2017060627","article-title":"The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes","volume":"29","author":"Y Kim","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"pone.0230227.ref029","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.metabol.2018.02.004","article-title":"Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy","volume":"85","author":"SR Choi","year":"2018","journal-title":"Metabolism"},{"key":"pone.0230227.ref030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1113\/jphysiol.2002.029306","article-title":"Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle","volume":"546","author":"T Kitazawa","year":"2003","journal-title":"J Physiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T17:40:56Z","timestamp":1584466856000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230227"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230227","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]}}}